Background Image
Table of Contents Table of Contents
Previous Page  31 / 62 Next Page
Information
Show Menu
Previous Page 31 / 62 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 4, July/August 2020

AFRICA

193

548 BP measurements (median of four per patient) showed that

increase in BP over a median follow up of 2.3 years (IQR: 1.5–2.6)

was associated with established risk factors for hypertension,

and that there was no evidence of an independent deleterious

effect of any class of anti-retroviral drugs on BP.

23

We therefore

recommend studies to unveil the effects in highly prevalent areas

for hypertension, such as the case of Mozambique.

24

A high prevalence of RHD (30.4/1 000) has been reported

in schoolchildren from the geographical area where the

study was undertaken.

5

Researchers in Uganda suggested a

possible protective role of HIV infection in modulating RHD

susceptibility. Borderline/definite RHD prevalence of 0.82%

(95% CI: 0.26–2.23%) was found on echocardiographic screening

of HIV-infected children, a low prevalence compared to the

1.5–4% prevalence among Ugandan children.

25

In Africa, anaemia has been linked to recurrent episodes

of malaria, tropical splenomegaly, parasitic intestinal disease,

among other infectious and nutritional causes. Because it is

the most common adverse effect of ART

26,27

and frequently

occurs independent of HIV infection,

28

moderate to severe

anaemia is often left untreated; this was the case in our cohort.

Several anaemic patients were found without any treatment,

despite levels of haemoglobin well below the internationally

recommended cut-off points.

We advocate that anaemia should be considered a risk factor

for several cardiovascular conditions affecting HIV patients,

including heart failure and cardiomyopathy.

29

It has been linked

to poorer virological suppression in Uganda.

30

Without targeted

measures for its correction, it persists in a considerable proportion

of patients after 12 months of ART.

31

More importantly, the

resolution of HIV-related anaemia has been proven to improve

quality of life, physical functioning, energy and fatigue.

16

Systolic and diastolic dysfunction were common in

paucisymptomatic HIV-infected patients. A meta-analysis by

Cerrato

et al

., to appraise the incidence of cardiac dysfunction in

HIV-infected paucisymptomatic individuals, performed a pooled

analysis of 2 242 patients from 11 studies.

32

An overall average

incidence of systolic and diastolic left ventricular dysfunction

of 8.3% (95% CI: 2.20–14.25) and 43.4% (95% CI: 31.73–55.03),

respectively, was found. Hypertension (OR = 2.30; 95% CI:

1.20–4.50) and older age (OR = 2.50 per 10 years’ increase; 95%

CI: 1.70–3.60) were predictors of LV diastolic dysfunction.

32

Themortality rate of 2.4%at two years occurred predominantly

in patients with cardiovascular disease (four out of six). It could

have been prevented by surgery (RHD and CHD), indicating

the need for efforts to invest in improving access to diagnosis

and management of chronic cardiovascular diseases in endemic

areas for HIV in Africa. Also, we performed a follow-up

ultrasound for 14.2% of patients (44/252) at 24 months. We were

able to determine the vital status and confirm the absence of

symptomatic heart failure for all participants at five years, by

medical visits, consultation of their hospital files and phone calls.

At the five-year follow up there were 24 (9.5%) deaths.

Programmes by non-physicians

33,34

to screen for cardiac

disease have shown that non-specialists can perform focused

cardiac ultrasound and use algorithms for risk stratification

and management. We believe that, supported by robust referral

systems to ensure that high-risk patients reach specialist care,

these task-shifting strategies should be considered for under-

resourced areas in sub-Saharan Africa because of their potential

to maximise the gains obtained with the dissemination of ART.

HIV infection in older people occurs concomitantly with some

cardiovascular risk factors and may require multidisciplinary

care.

35

Our results not only corroborate the association of HIV

and ART with cardiometabolic traits in sub-Saharan Africa,

36

but also support systematic cardiovascular screening in younger

people on ART. Furthermore, owing to the mounting evidence

showing that countries with a high burden of HIV also have

an increased burden of non-communicable diseases such as

hypertension,

37

economic implications on the already under-

resourced health systems in Africa need to be considered.

Conclusions

Cardiovascular risk and disease was evident in HIV-infected

individuals in a cohort of relatively young patients on long-

US – cardiac ultrasound

264 recruited

12 did not have US

252 with US

Lost to follow-up 3

(1.2%)

Lost to follow-up 5

(2.1%)

6 deaths

(2.4%)

220 with follow-up

(90.5%)

243 with US

(96.4%)

Deaths 18

(7.4%)

Baseline

24-month follow-up

5-year follow-up

Fig. 1.

Flowchart of the study.